In tumor tissues, LIF has been shown to be overexpressed and is demonstrated to independently serve as a predictive indicator for patients with various malignant tumors, such as gastric cancer, colorectal cancer, esophageal adenocarcinoma, and gallbladder carcinoma [36]. The gene discussed is LIF; the disease is colorectal cancer.